N-RAS AND K-RAS ONCOGENES IN PLASMA-CELL DYSCRASIAS

被引：23

作者：

CORRADINI, P

LADETTO, M

INGHIRAMI, G

BOCCADORO, M

PILERI, A

机构：

[1] Department of Medicine and Experimental Oncology Division of Hematology, University of Torino

[2] Department of Pathology, New York University

来源：

LEUKEMIA & LYMPHOMA | 1994年 / 15卷 / 1-2期

关键词：

RAS ONCOGENES; PLASMA CELL LEUKEMIA; MULTIPLE MYELOMA; MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE;

D O I：

10.3109/10428199409051673

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

N- and K-ras oncogene mutations represent the most frequent molecular lesions in plasma cell dyscrasias. They are not randomly distributed since they are detectable in multiple myeloma (MM) (9-31%) and plasma cell leukemia (PCL) (30%), and not in monoclonal gammopathy of undetermined significance (MGUS) and solitary plasmacytoma (SP). Codons 12, 13 and 61 of N- and K-ras genes have been found mutated. Mutations affecting codon 61 of N-ras gene are the most frequent finding. A heterogeneous pattern of mutations is described with a prevalence of purine-pyrimidine transversions. Ras gene mutations have been predominantly detected in myelomas characterized by an advanced stage disease, and adverse prognostic parameters. These findings suggest that ras mutations represent a late molecular lesion and may be implicated in tumor progression rather than tumor initiation.

引用

页码：17 / 20

页数：4

共 30 条

[11]

Barbacid M., Ras genes, Annu. Rev. Biochem., 56, pp. 779-827, (1987)

[12]

Gaidano G., Dalla Favera R., Protooncogenes and tumor suppressor genes, Neoplastic Hematopathology, pp. 245-261, (1992)

[13]

Jiang W., Kahn S.M., Guillem J.G., Lu S.H., Wein-Stein I.B., Rapid detection of ras oncogenes in human tumors: Applications to colon, esophageal, and gastric cancer, Oncogene, 4, pp. 923-928, (1989)

[14]

Bos J.L., Ras oncogenes in human cancer: A review, Cancer Res., 49, pp. 4682-4689, (1989)

[15]

Toksoz D., Farr C.J., Marshall C.J., Ras genes and acute leukemia, Br. J. Haematol., 71, pp. 1-6, (1989)

[16]

Ahuja H.G., Foti A., Bar-Eli M., Cline M.J., The pattern of mutational involvement of ras genes in human hematologic malignancies determined by DNA amplification and direct sequencing, Blood, 75, pp. 1684-1690, (1990)

[17]

Bos J.L., Verlaan-De Vries M., van der Eb J., Janssen J.W.G., Delwel R., Lowenberg B., Colly L.P., Mutations in N-Ras predominate in acute myeloid leukemia, Blood, 69, pp. 1237-1241, (1987)

[18]

Neri A., Knowles D.M., Greco A., McCormick F., Dalla and Favera R., Analysis of ras oncogene mutations in human lymphoid malignancies, Proc. Natl. Acad. Sci. USA, 85, pp. 9268-9272, (1988)

[19]

Orita M., Suzuki Y., Sekiya T., Hayashi K., Rapid and sensitive detection of point mutations and DNA polymorphism using the polymerase chain reaction, Genomics, 5, pp. 874-882, (1989)

[20]

Portier M., Moles J.P., Mazars G.R., Jeanteur P., Ba-Taille R., Klein B., Theillet C., p53 and ras gene mutations in multiple myeloma, Oncogene, 7, pp. 2539-2543, (1992)

← 1 2 3 →